FLINT, Mich., Aug. 30, 2018 /PRNewswire/ -- Diplomat
Pharmacy, Inc. (NYSE: DPLO), executives will present at three
upcoming investor conferences.
Baird Global Healthcare Conference in New York: Atul
Kavthekar, chief financial officer, will present at
9:40 a.m. ET. Sept. 5.
Wells Fargo Securities Healthcare Conference in Boston: Brian
Griffin, chairman and chief executive officer, and
Atul Kavthekar, chief financial
officer, will present at 8 a.m. ET.
Sept. 6.
Morgan Stanley Global Healthcare Conference in New York: Brian
Griffin, chairman and CEO; Joel
Saban, president; and Atul
Kavthekar, chief financial officer, will present at
11:40 a.m. ET. Sept. 12.
Live audio webcasts of each presentation will be available on
the investor relations section of Diplomat's website at
ir.diplomat.is. Recordings will be available for approximately 90
days following each presentation at the same URL.
To learn more about Diplomat, visit diplomat.is.
About Diplomat
Diplomat (NYSE: DPLO) is the nation's
largest independent provider of specialty pharmacy and infusion
services. Diplomat helps people with complex and chronic health
conditions in all 50 states, partnering with payers, providers,
hospitals, manufacturers, and more. Rooted in this patient care
expertise, Diplomat also serves payers through CastiaRx, a leading
specialty benefit manager, and offers tailored solutions for
healthcare innovators through EnvoyHealth. Diplomat opened its
doors in 1975 as a neighborhood pharmacy with one essential tenet:
"Take good care of patients and the rest falls into place." Today,
that tradition continues—always focused on improving patient care.
For more information, visit diplomat.is.
INVESTOR CONTACT:
Terri Anne Powers, Vice
President,
Investor Relations
312.889.5244 | tpowers@diplomat.is
MEDIA CONTACT:
Jenny
Cretu, Senior Vice President,
Pharma Services and Marketing
810.768.9370 | jcretu@diplomat.is
View original content with
multimedia:http://www.prnewswire.com/news-releases/diplomat-to-participate-in-upcoming-investor-conferences-300705090.html
SOURCE Diplomat Pharmacy, Inc.